Introduction
Schistosomiasis, which affects more than 200 million people, is the most prevalent form of hepatic fibrosis worldwide (1) . Its pathogenesis is characterized by a cellular immune response (particularly of the delayed type) induced by parasite eggs, which are trapped in the perisinusoidal areas of the host liver, and which cause a granulomatous reaction and a subsequent marked periportal fibrosis (2, 3) .
Until seVeral years ago, fibrosis was only defined by an excessive deposition of collagen and other components of the extracellular matrix (4) . Npw, according to Gr essner (5) , the definition of fibrosis must take into account the c mplexity of the changes of the liver extracellular matrix (6) (7) (8) (9) , including an increase, but not all to the same extent, of the contents of most of the extracellular matrix molecules, some changes of their microcomposition, and their topographic redistrib tion. Among the different collagens present in the liver (types Ι, ΙΙΪ, IV, V and VI), types I and III are the most abundant, type III being deposited first, followed by type I during to fibrotic process (6 -11) .
Since 1979, several attempts have been made to evaluate, in biological fluids, the metabolism of human connective tissue proteins, using radioimmunoassay techniques (12) (13) . Much has been published on the aminoterminal propeptide of type III procollagen. For serum, the aminoterminal propeptide of type III procollagen levels are increased in various hepatic diseases, and this was interpreted in earlier studies in terms of increased liver collagen synthesis and degradation (14) . The relationship between aminoterminal propeptide of type III procollagen and aminotransferase concentrations in serum suggests in fact that the peptide may be released during the active inflammatory phase of the disease by cleavage of tissue III procollagen, thus reflecting inflammation and necrosis and not necessarily fibrosis (13, 15) .
In schistosomal liver fibrosis, in contrast to other chronic liver diseases, there is a primary hepatic fibrosis with little necrosis. In Order to assess the value of aminoterminal propeptide of type III procollagen during evolution of fibrosis, we have measured aminoterminal propeptide of type III procollagen levels in schistosomal patients with active and inactive fibrosis. In endemic areas for schistosomiasis and Hepatitis, both diseases can be simultaneously present in the same patients, which may result in a more severe form of chronic liver disease. In the present study we therefore retained only patients without associated hepatitis B infection.
Laboratory investigations

Biochemical determinations
Liver function tests were performed on sera according to the Standard methods using commercial kits (Boehringer Mannheim, Mannheim, Germany). They included: aspartate aminotransferase, alanine aminotransferase, γ-glutamyl transpeptidase, alkaline phosphatase, total bilirubin. Electrophoresis was also performecl on sera.
Materials and Methods
Subjects
Healthy subjects (members of the medical and non-medical staff of the Theodor Bilharz Research Institute) were used s controls (n = 44); they had no history of schistosomiasis or liver disease.
Patients from endemic areas for schistosomiasis with an hepatosplenic affection were admitted to Theodor Bilharz Research Institute. All subjects were over 17 years old and had normal kidney function s demonstrated by normal creatinine clearance. All patients were subjected to complete clinical examination. They had no evidence of rheumatic diseases. Rectosigmo'idoscopic examinations and stool analysis were performed and showed living or dead Schistosoma mansoni eggs. No Schistosoma haematobium eggs were detected in urine.
Liver biopsies were taken from all patients. Liver sections were stained with haematoxylin and eosin, and Masson trichrome. According to the histopathological pattern, only the cases with pure schistosomal liver fibrosis were selected (n == 29). In pure schistosomal liver fibrosis, the lobular architecture was preserved with no evidence of necrosis or regeneration; the evidence for schistosomiasis was demonstrated by the presence of eggs, granuloma or pigments. This group was further divided according to the degree of inflammatory cell Infiltration and the activity of fibrosis (16) 
Radioimmunoassay of aminoterminal propeptide oftype III procollagen
Bovine p-N-Ill coliagen and aminoterminal propeptide of type III procollagen (Col 1-3) extracted from fetal calf skin and rabbit antiserum to purified p-N-lll coliagen (17) The sensitivity of the assay was l μg/l. The within and between assays coefficients of Variation were less than 15% (for concentrations ranging between 2 and 150 μg/l). The upper limit of normal values (mean ± 2 SD) was established s 15 μg/l (Harl· mann et al., in preparation). To determine the molecular mass of immunoreactive components in serum, we chromatographed 2 ml of normal human serum on a 1.6 χ 130 cm column of Sephacryl S 500 (Pharmacia, Uppsala, Sweden) equilibrated in phosphate bufiferfed saline containing 0.4 ml of TXveen 20 per liter, eluting at a flow rate of 20 ml/h. We collected and assayed 1.5 ml fractions. This assay mainly recognized intact aminoterminal propeptide of type III procollagen and high molecular weight components, and small degradation products such s Col-1 were recognized weakly, if at all ( fig. 2 ).
Data were analysed for statistical significance by the unpaired Mann-Whitney U test. The non-parametric Spearman rank correlation coefficients were calculated (Statgraphics® Software, STSC). 
Results
Results of the liver function tests in patients and normal controls are summarized in table 2. Serum levels of aminoterminal pr peptide of type III procollagen in all patients (14.2 ± 6.2 μg/l) (mean + SD) were higher than those in controls (11.4 ± 2.0 μg/l) (p = 0.05) (t b. 3 and fig. 3 ). Patients with active liver fibrosis had higher aminoterminal propeptide of type III procollagen values (16.9 ± 5.7 μ^/1) than patients with inactive liver fibrosis (9.1 ±3.5 μg/l) (p < 0.001). n: number of subjects
Discussion
During schistosomiasis a greatly increased total hepatic collagen content has been demonstrated (10) . The various types of the deposited collagen have been characterized by immunocytochemistry at different stages of schistosome granulomata (18, 19) and thus collagen typing has become important in the evaluation of the dynamics and prognosis of hepatic fibrosis. Until recently, histological examination of biopsies was therefore the only reliable method for determining the extent and progress of fibrosis in the liver.
In liver diseases, the measurement of aminoterminal propeptide of type III procollagen in serum by radioimmunoassay has been proposed äs a non^invasive parameter. The antigens recognized in the different aminoterminal propeptide of type III procollagen assays were found to be heterogeneous in human serum, where there are at least 4 immunoreactive forms which differ in their molecular size (13) . Aminoterminal propeptide of type III procollagen is the intact trimeric aminoterminal propeptide of collagen III (Col l -3) with a molecular mass of M r = 45 000 (14, 20) . Its degradation product, Col-1 (M T = 10000), is only weakly cross-reactive in the conventional aminoterminal propeptide of type III procollagen RIA (14) . There are also larger forms recognized by the antibodies: one may represent type procollagen of p-N-III collagen, the other, somewhat larger than the propeptide, may be aggregated aminoterminal pro* peptide of type III procollagen or a degradation product of type III procollagen. Moreover their proportion may vary in patient serum according to the disease and even during the different phases of a given disease (13) . In addition, these circulating antigens do not present the same affinity for the antibody äs does purified aminoterminal propeptide of type III procollagen. Thus, the apparent proportions of the different forms in any serum sample can vary according to the antisera and the assay conditions used.
The first radipimmunoassay for aminoterminal propeptide of type III procollagen was described by Rohde (14) ; the curve slope was less steep than that for the bovine reference peptide, so the following improvements were proposed. In order to quantitate mainly the low molecular forms, Pierard et al. (17) reported a modified radioimmunoassay using äs Standard the antigen generated by cleavage of bovine aminoterminal propeptide of type III procollagen with bacterial collagenase (Col-1 plus Col-2), while Rohde et al. (21) introduced an assay using pepsincleaved antibody (F ab fragments), the affinity of the intact propeptide and its degradation product (Col-1) to these F ab being nearly identical. In contrast, Risteli et al. (22) recently used a highly purified human antigen, and did not detect the small aminoterminal propeptide of type III procollagen degradation products in serum.
In this study we used the assay of Pierard et al. (17) with some modifieations, with Col l -3 äs a Standard. Under the chosen reaction coh'ditiöns (22) (Harmann et al., in preparation), the reactivity of small degradation products was reduced ( fig. 2 ) and the displacement curves obtained with the antigen and serially diluted human sera were parallel ( fig. 1 ).
An increased serum aminoterminal propeptide of type III procollagen might reflect a de novo synthesis of type III procollagen in the liver, since the aminop ropeptide is partly liberated during the conversion of procollagen into collagen in stoichiometric amounts, but it may also reflect the degradation of tissue type III collagen still containing the aminoterminal propeptide (13, 15) .
We found that serum aminoterminal propeptide of type III procollagen was elevated in most of patients with an active stage of schistosomal liver fibrosis and not during an inactive stage. Such an increase may be attributed to an increased collagen synthesis (correlated with higher levels of synthesis enzymes) and/ or also to enhancement of collagenolytic activities in the early stages of schistosomiasis (8, 23) . The lower serum levels observed in schistosomal patients with inactive liver fibrosis may be related to the absence of (or minimal) fibrogenic activity (synthesis or degradation) and/or to an increased deposition of type l collagen rather than type III collagen in the liver during this stage. Our findings are in agreement with El-Mohandes et al. (16) and Bolarin et al. (23) for schistosomiasis, and also with studies on other liver diseases (14, (24) (25) (26) (27) , showing that aminoterminal propeptide of type III procollagen is likely to be a marker of disease activity. The present data show no correlation between aminoterminal propeptide of type III procollagen and aspartate aminotransferase or alanine aminotransferase in patients with an inactive or an active stage, in contrast to what has been observed in other situations (14, 24, 27) . However this result is an agreement with ELMohandes et al. (16) and Roberts et al. data (28) : in patients with schistosomiasis, increased aminoterminal propeptide of type III procollagen serum levels were reported, but without any correlation with necrosis. As serum aminoterminal propeptide of type 111 procollagen is likely to be modified during granuJoma resorption due to increased collagenolytic activities, riatürally (8, 11) or after treatment with praziquantel (29), we have undertaken follow-up studies of individuals to assess the prognostic value of aminoterminal propeptide of type III procollagen and its usefulness during antischistosomal chemotherapy.
